Agfa-Gevaert's Preliminary 2010 Results in Line with its Guidance

Agfa HealthCareThe Agfa-Gevaert Group's full year revenue amounted to 2,948 million Euro, an increase of 7.0 percent (3.2 percent excluding currency effects) compared to 2009. About half of this growth is related to Agfa Graphics' joint venture in China and the Pitman acquisition.

The Agfa-Gevaert Group's total 2010 EBIT is expected to be approximately 266 million Euro (9.0 percent of revenue), versus 182 million Euro (6.6 percent of revenue) in 2009.

The full year net result is expected to be above 100 million Euro, versus 6 million Euro in 2009.

At year end, net debt stood at 161 million Euro, compared to 445 million Euro at the end of 2009.

In spite of the uncertainties that the graphic markets faced in the fourth quarter, particularly in Europe, the revenue of the Agfa Graphics business group amounted to 1,565 million Euro. Excluding currency effects, the increase would amount to 12.2 percent.

Agfa Graphics' EBIT is expected to be about 134 million Euro (8.6 percent of revenue), compared to 63 million Euro in 2009 (4.7 percent of revenue).

Agfa HealthCare's full year revenue is almost stable at 1,180 million Euro. Excluding currency effects, a decrease of 3.3 percent would have been posted. Agfa HealthCare expects that the growth of the IT division will start to compensate for the revenue decline in the traditional business in the course of the second half of 2011.

Agfa HealthCare's EBIT is expected to amount to approximately 126 million Euro (10.7 percent of revenue), versus 116 million Euro in 2009 (9.8 percent of revenue).

The revenue of the smaller Agfa Specialty Products business group amounted to 203 million Euro, a decrease by 14.0 percent (15.4 percent excluding currency effects), mainly because of the shift of part of the film business to Agfa Graphics and the market-driven decline for some of the Classic Film products.

Agfa Specialty Products' EBIT is expected to amount to approximately 8 million Euro (3.9 percent of revenue), versus 13 million Euro in 2009 (5.5 percent of revenue).

Agfa-Gevaert's CEO Christian Reinaudo commented: "Both in terms of top line and in terms of EBIT, our 2010 results are in line with the outlook we gave in August. Driven by Agfa Graphics, we posted a revenue increase close to 200 million Euro. Both Agfa Graphics and Agfa HealthCare met their EBIT targets. So far, we only saw limited effects of the high raw material costs. The raw material related impact on the margins is expected to be more substantial as from the first quarter of this year. The effects of the recently announced price increases for our film products are expected to become more visible in the course of the second half of the year. In spite of the adverse situation on the raw material markets, we maintain - for the medium term - our average EBIT guidance."

Agfa-Gevaert will disclose its complete and fully audited 2010 results on March 25.

Related news articles:

About Agfa-Gevaert
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials).

Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...